Han Meihong, Yang Zhen
Department of Infectious Diseases, Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong.
Medicine (Baltimore). 2025 Jul 4;104(27):e43080. doi: 10.1097/MD.0000000000043080.
Wilson disease (WD) is an autosomal recessive disorder in which mutations in ATP7B lead to excessive copper deposition in the liver, brain, eyes, kidneys, and other organs. Patients with WD can present with hepatic dysfunction, neurological symptoms, rare hemolytic anemia, and renal tubular acidosis.
A 27-year-old female patient with liver cirrhosis and maturity-onset diabetes of the young was found to have normal serum ceruloplasmin (25.9, 20-60 mg/dL) and copper levels (17.81, 12.6-23.6 μmol/L).
Liver biopsy revealed severe lobular hepatitis (multiple lobular/large necroses), early cirrhosis with a small amount of copper deposits, hepatocyte lipidosis, balloon-like changes, Mallory bodies, and glycogenated hepatocyte nuclei. Genetic analysis of ATP7B exon found 2 variants (c.2333G>T, p. Arg778Leu) in exon 8 and (c.3209C>G, p. Pro1070Arg) in exon 14. Based on the available results, the Leipzig score was 7 and the diagnosis of WD can be confirmed. A late Kayser-Fleischer corneal rings test came back positive.
The patient's clinical management included d-penicillamine and insulin.
At approximately 6 months of follow-up, the patient's liver function was well controlled and the cirrhosis did not progress or have decompensated events.
Although WD is treatable, its early detection is challenging. Genetic testing and liver pathology are sometimes necessary for the diagnosis of WD. This case underscores the consideration of WD in the differential diagnosis of patients with liver cirrhosis. Normal ceruloplasmin levels do not rule out WD.
威尔逊病(WD)是一种常染色体隐性疾病,其中ATP7B基因突变导致肝脏、大脑、眼睛、肾脏和其他器官中铜过度沉积。WD患者可能出现肝功能障碍、神经症状、罕见的溶血性贫血和肾小管酸中毒。
一名27岁患有肝硬化和青年发病型糖尿病的女性患者,血清铜蓝蛋白水平正常(25.9,20 - 60mg/dL),铜水平正常(17.81,12.6 - 23.6μmol/L)。
肝活检显示严重小叶性肝炎(多个小叶/大片坏死)、早期肝硬化伴少量铜沉积、肝细胞脂肪变性、气球样变、马洛里小体和糖原化肝细胞核。ATP7B外显子的基因分析发现外显子8有2个变异(c.2333G>T,p.Arg778Leu),外显子14有(c.3209C>G,p.Pro1070Arg)。根据现有结果,莱比锡评分7分,可确诊WD。后期凯泽 - 弗莱舍尔角膜环试验呈阳性。
患者的临床治疗包括使用青霉胺和胰岛素。
在大约6个月的随访中,患者的肝功能得到良好控制,肝硬化未进展或出现失代偿事件。
虽然WD是可治疗的,但其早期检测具有挑战性。基因检测和肝脏病理学检查有时对于WD的诊断是必要的。该病例强调在肝硬化患者的鉴别诊断中应考虑WD。正常的铜蓝蛋白水平不能排除WD。